查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1708215

多核苷酸注射劑市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Polynucleotides Injectables Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球多核苷酸注射劑市場價值為 1.278 億美元，預計將經歷強勁成長，2025 年至 2034 年期間的複合年成長率為 15.3%。這些注射治療含有純化的 DNA 片段，主要用於再生醫學和美容應用。它們具有促進組織再生、減少發炎和增強保濕的能力，因此在改善皮膚彈性、促進組織修復和支持關節健康方面備受追捧。由於消費者對非侵入性手術及其已證實的益處的興趣日益濃厚，推動了對這些先進治療方法的需求，市場也因此而受到青睞。政府政策和監管部門的批准也在推動市場成長方面發揮關鍵作用，為在臨床和美容環境中採用多核苷酸注射劑創造了良好的環境。

多核苷酸注射劑市場 - IMG1

在各種應用中，眼部治療已成為市場的主要部分。到 2024 年，該部分將佔市場收入的 62.3%，預計其成長仍將持續。注射劑透過刺激膠原蛋白的產生和增強皮膚彈性，可以有效解決眼窩凹陷、皺紋和黑眼圈等美容問題。這些非侵入性治療方法的流行使其成為希望恢復眼部敏感皮膚活力的個人的首選。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 1.278億美元
預測值 5.257億美元
複合年成長率 15.3%

醫療水療中心已成為市場的主要推動力，為市場擴張做出了重大貢獻。這些水療中心佔據了總市場佔有率的 48.5%，2024 年創造了 6,200 萬美元的收入。隨著非手術美容療程越來越受歡迎，消費者擴大選擇醫療水療中心，因為它們方便、實惠，並且能夠提供個人化的解決方案。對最短恢復時間和自然效果的偏好進一步刺激了這些機構對多核苷酸注射劑的需求。

從地理上看，北美預計將引領市場成長，預計 2024 年營收將達到 5,300 萬美元。美國預計將佔據主導地位，2023 年貢獻 4,060 萬美元，這得益於高可支配收入和高階自我照護治療日益成長的趨勢。隨著該地區的消費者越來越重視非侵入性手術和美容健康，對多核苷酸注射劑的需求將會上升，進一步推動市場擴張。

隨著這些注射劑在醫療和美容用途中的應用越來越廣泛，預計其市場將在各個地區繼續穩步成長，特別是在醫療水療和眼部治療應用領域。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 對美學和再生解決方案的需求不斷增加
      • 多核苷酸注射技術的進展
      • 消費者對美容皮膚護理的認知不斷提高
      • 有利的監管批准
    • 產業陷阱與挑戰
      • 副作用和安全問題
      • 成本高且可近性有限
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按應用，2021 - 2034 年

  • 主要趨勢
  • 眼睛
  • 嘴唇
  • 前額
  • 下顎線和顴骨
  • 其他應用

第6章：市場估計與預測：依最終用途，2021 - 2034 年

  • 主要趨勢
  • 醫療水療中心
  • 美容及整容中心
  • 醫院

第7章：市場估計與預測：按地區，2021-2034

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第8章：公司簡介

  • AMEELA
  • BR Pharm
  • Croma Pharma
  • DermaFocus
  • Fox Pharma
  • Genoss
  • Lkc Pharma
  • Mastelli
  • Pluryal
  • Promoitalia Laboratories
簡介目錄
Product Code: 13350

The Global Polynucleotides Injectables Market, valued at USD 127.8 million in 2024, is projected to experience robust growth, expanding at a CAGR of 15.3% between 2025 and 2034. These injectable treatments, which contain purified DNA fragments, are primarily used in regenerative medicine and aesthetic applications. Their ability to promote tissue regeneration, reduce inflammation, and enhance hydration makes them highly sought after for improving skin elasticity, encouraging tissue repair, and supporting joint health. The market is gaining traction due to increasing consumer interest in non-invasive procedures and their proven benefits, driving demand for these advanced treatments. Government policies and regulatory approvals also play a critical role in propelling market growth, creating a favorable environment for the adoption of polynucleotide injectables in both clinical and aesthetic settings.

Polynucleotides Injectables Market - IMG1

Among the various applications, eye treatment has emerged as the dominant segment in the market. By 2024, this segment accounted for 62.3% of market revenue, and its growth is expected to continue. The injectables are highly effective in addressing cosmetic concerns such as under-eye hollows, wrinkles, and dark circles by stimulating collagen production and enhancing skin elasticity. The popularity of these treatments in non-invasive procedures has positioned them as a preferred option for individuals looking to rejuvenate the sensitive skin around the eyes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$127.8 Million
Forecast Value$525.7 Million
CAGR15.3%

Medical spas have become a major driving force in the market, contributing significantly to its expansion. These spas accounted for 48.5% of the total market share, generating USD 62 million in 2024. As non-surgical aesthetic treatments gain popularity, consumers increasingly choose medical spas for their convenience, affordability, and ability to provide personalized solutions. The preference for minimal recovery time and natural-looking results further boosts the demand for polynucleotide injectables in these establishments.

Geographically, North America is expected to lead the market growth, with revenues projected to reach USD 53 million in 2024. The U.S. is expected to dominate, contributing USD 40.6 million in 2023, driven by a high disposable income and a growing trend toward premium self-care treatments. As consumers in the region increasingly prioritize non-invasive procedures and aesthetic wellness, the demand for polynucleotide injectables is set to rise, further fueling market expansion.

As these injectables become more widely used for both medical and cosmetic purposes, their market is anticipated to continue growing steadily across various regions, particularly in medical spas and eye treatment applications.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° Synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for aesthetic and regenerative solutions
      • 3.2.1.2 Advancements in polynucleotide injectable technologies
      • 3.2.1.3 Growing consumer awareness about aesthetic skin treatments
      • 3.2.1.4 Favorable regulatory approvals
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Side effects and safety concerns
      • 3.2.2.2 High costs and limited accessibility
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Eyes
  • 5.3 Lips
  • 5.4 Forehead
  • 5.5 Jawline and cheekbones
  • 5.6 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Medical spas
  • 6.3 Aesthetic and cosmetic centers
  • 6.4 Hospitals

Chapter 7 Market Estimates and Forecast, By Region, 2021- 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 AMEELA
  • 8.2 BR Pharm
  • 8.3 Croma Pharma
  • 8.4 DermaFocus
  • 8.5 Fox Pharma
  • 8.6 Genoss
  • 8.7 Lkc Pharma
  • 8.8 Mastelli
  • 8.9 Pluryal
  • 8.10 Promoitalia Laboratories